Skip to main content

Total Body Irradiation

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

DxTerity
DxTerityCA - Torrance
1 program
Gene Expression That Predicts Radiation Exposure in HumansN/A1 trial
Active Trials
NCT03123133Completed151Est. Jul 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
DxTerityGene Expression That Predicts Radiation Exposure in Humans

Clinical Trials (1)

Total enrollment: 151 patients across 1 trials

NCT03123133DxTerityGene Expression That Predicts Radiation Exposure in Humans

Gene Expression That Predicts Radiation Exposure in Humans

Start: Apr 2017Est. completion: Jul 2020151 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.